Marshall Wace North America’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-24,700
| Closed | -$2.22M | – | 1464 |
|
|
2021
Q1 | $2.22M | Buy |
+24,700
| New | +$2.22M | 0.01% | 784 |
|
|
2020
Q3 | – | Sell |
-5,880
| Closed | -$596K | – | 1269 |
|
|
2020
Q2 | $596K | Sell |
5,880
-2,256
| -28% | -$229K | ﹤0.01% | 891 |
|
|
2020
Q1 | $548K | Buy |
8,136
+1,660
| +26% | +$112K | ﹤0.01% | 736 |
|
|
2019
Q4 | $354K | Sell |
6,476
-96,416
| -94% | -$5.27M | ﹤0.01% | 876 |
|
|
2019
Q3 | $3.84M | Buy |
+102,892
| New | +$3.84M | 0.02% | 416 |
|
|
2018
Q4 | – | Sell |
-126,768
| Closed | -$4.53M | – | 1512 |
|
|
2018
Q3 | $4.53M | Buy |
126,768
+49,724
| +65% | +$1.78M | 0.03% | 338 |
|
|
2018
Q2 | $1.83M | Sell |
77,044
-181,788
| -70% | -$4.32M | 0.01% | 789 |
|
|
2018
Q1 | $4.8M | Buy |
+258,832
| New | +$4.8M | 0.02% | 581 |
|
|
2013
Q4 | – | Sell |
-518,928
| Closed | -$3.66M | – | 727 |
|
|
2013
Q3 | $3.66M | Buy |
+518,928
| New | +$3.66M | 0.11% | 198 |
|